The American Society of Nephrology’s Kidney Week 2017, which runs from October 31 to November 5 in New Orleans, is expected to draw more than 12,000 individuals from over 100 countries. Researchers from around the world are scheduled to present findings from 3696 studies in oral and poster presentations, which were selected from 4454 abstracts submitted.
Program chair Susan M. Wall, MD, professor of medicine at Emory University School of Medicine in Atlanta, said attendees can expect to see a large increase in the number of studies examining the pathogenesis of acute and chronic kidney disease compared with previous meetings.
This year’s meeting will offer attendees some new early programs. These include a 2-day program (October 31 to November 1) titled “Precision Medicine in Renal Diseases,” part of the Advances in Research Conference, which Dr Wall said is among the meeting’s highlights. The topic is an area that will likely be incorporated into the future practice of nephrology.
Other new 2-day programs include “Advancing Clinical Research in Nephrology: Approaches and Methods” and “What You Need to Know about Diabetes and Diabetic Kidney Disease.”
Dr Wall also emphasized the slate of experts scheduled to participate in the State-of-Art Lectures, including Brian K. Kobilka, MD, of Stanford University, a co-recipient of the 2012 Nobel Prize in Chemistry, whose talk will be on G protein coupled receptors and their implications for drug discovery. Laura E. Niklason, MD, PhD, of Yale University, will speak about human engineered tissues for dialysis access, Andrew P. Feinberg, MD, MPH, of Johns Hopkins University, will discuss epigenetics, and Richard A. Flavell, PhD, of Yale University, will inform attendees about innate immunity in tissue injury and inflammation. Dr Wall pointed out that all of these speakers are outstanding basic scientists with a message that is highly relevant to the practice of nephrology.